LGALS1 and lung carcinoma: According to our previous studies shown in Fig. 1A, cut off value was set to 49.84 ng/ml, namely the median of serum galectin-1 level of the patients with advanced lung cancers (stage III and IV) subtract 1.96 times of SD, which included 95% of patients in stage III and IV.